SCHEMBL14877947

SCHEMBL14877947

CCCN(C)CCNC(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.49
CA1 P00915 4/20 0.49
CA7 P43166 1/20 0.49
CA14 Q9ULX7 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
CKS1B P61024 1/20 0.41
SKP1 P63208 1/20 0.41
SKP2 Q13309 1/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
EPHX1 P07099 1/20 0.41
MALT1 Q9UDY8 1/20 0.39
DRD2 P14416 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13055395 0.93 TDP1 (0.55) CA12CA1CA7CA14TDP1
SCHEMBL1677981 0.89 TDP1 (0.49) CA12CA1CA7CA14TDP1
SCHEMBL26157819 0.89 TDP1 (0.57) CA12CA1CA7CA14TDP1
SCHEMBL25531030 0.88 TDP1 (0.50) CA12CA1CA7CA14TDP1
SCHEMBL3098926 0.87 TDP1 (0.51) CA12CA1CA7CA14TDP1
SCHEMBL17209068 0.86 TDP1 (0.49) CA12CA1CA7CA14TDP1
SCHEMBL5327354 0.86 TDP1 (0.57) CA12CA1CA7CA14TDP1
SCHEMBL1584879 0.85 TDP1 (0.47) CA12CA1CA7CA14TDP1
SCHEMBL8286297 0.85 TDP1 (0.47) CA12CA1CA7CA14TDP1
SCHEMBL18429539 0.85 MEN1 (0.49) CA12CA1CA7CA14TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023177976-A2 NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF PROMEGA CORPORATION (US) 2023-09-21 WO disclosed
WO-2017037670-A1 SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS OncoArendi Therapeutics Sp. z o.o. (PL) 2017-03-09 WO disclosed
US-8426105-B2 Resist-modifying composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-04-23 US disclosed